Jaclyn R. Daniels

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

NCTR

Also affiliated: United States Food and Drug Administration (2017–2026)

5 h-index 8 pubs 175 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Jaclyn R. Daniels' research focuses on the identification and validation of proteomic biomarkers for predicting disease outcomes and treatment response. Her work has investigated biomarkers for acute kidney injury (AKI) recovery and mortality in dialysis-dependent patients, as well as predictive biomarkers for doxorubicin-induced cardiotoxicity in breast cancer patients. Daniels also studies the stability of the human plasma proteome, examining how pre-analytical variability affects proteomic measurements using aptamer-based approaches. She has explored integrated analyses of metabolites, peptides, and inflammation biomarkers to assess this variability. Her publications include work on exploratory biomarkers and analytical approaches, with a recent publication in 2026 on baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity.

Metrics

h-index: 5
Publications: 8
Citations: 175

Selected Publications

Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients (2026)

Cardio-Oncology DOI OpenAlex
Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients (2021)

Kidney360 34 citations DOI OpenAlex
Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach (2019)

Journal of Proteome Research 31 citations DOI OpenAlex
An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma (2019)

Journal of Proteome Research 27 citations DOI OpenAlex
An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability (2018)

The FASEB Journal DOI OpenAlex
Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients (2018)

Kidney International Reports 22 citations DOI OpenAlex
Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients (2017)

Experimental Biology and Medicine 56 citations DOI OpenAlex
Exploratory biomarkers: Analytical approaches and their implications (2017)

Current Opinion in Toxicology 3 citations DOI OpenAlex